by Protea Foundation | Aug 6, 2026 | News
The Protea Foundation is dedicated to closing the financial gap between what clients can afford for therapy and the true cost of effective treatment. Every dollar contributed goes directly to client care, prioritizing trauma-informed, evidence-based therapies that...
by Protea Foundation | Aug 12, 2024 | News
Statement by Protea Founder, Cristina Pearse: I am living proof that MDMA-Assisted Therapy (MDMA-AT) is safe, effective, life-changing, and even life-saving. By not approving MDMA-AT, the FDA is risking the lives of the 13 million+ Americans suffering from PTSD. ...
by Protea Foundation | Jul 1, 2024 | News
Ketamine Insights A Podcast about Psychedelic Medicine and New Depression Treatments Cristina Pearse is interviewed by Molly at Ketamine Insights about her experience and advocacy for MDMA-Assisted Therapy. Access the full podcast episode here on SPOTIFY. Access this...
by Protea Foundation | Jul 1, 2024 | News
Emory researchers studying psychedelic-assisted treatment for PTSD Atlanta university’s study comes as FDA evaluates treating disorder with MDMA, a psychedelic drug also known as ecstasy. Researchers at the Emory Brain Health Center are studying how MDMA — a...
by Protea Foundation | Jul 1, 2024 | News
BLOOMBERG: Illegal Ecstasy Takes Step Toward Becoming Legal Drug for PTSD Almost forty years after it was banned, it’s taking a big step toward becoming a licensed treatment for post traumatic stress disorder. Read the full article here. Excerpt: In 2014, MAPS founded...
by Protea Foundation | Jun 11, 2024 | News
During the FDA advisory committee hearing on June 4, 2024, our founder & CEO, Cristina Pearse, urged the committee to save lives by approving MDMA-Assisted Therapy. Here is the full link to The New York Times article. “Each day we postpone this therapy, I...
